A cross-sectional study directed by Almontashiri et al. revealed that during AMI, the PCSK9 plasma level was enhanced in individuals (non-diabetic) with angiographically-defined coronary artery disease [52]. The gene discussed is PCSK9; the disease is coronary artery disorder.